Today’s AI Top Pick: CRGY

CRGY is the only name in the pool, so this is a default winner — but the setup is genuinely mixed and deserves an honest read. On the bullish side: the stock passed the model_backed_squeeze screen with a 15.2% short float, forward P/E of just 4.85, PEG of 0.78, P/S of 0.9, analyst recom of 1.41 (strong buy), and a hefty 59.5% target upside. UBS just initiated coverage on 2026-07-15 with a Buy and $13 PT (~24% above the current $10.52), which is a fresh positive catalyst. Sales YoY of +18.27% and perfYtd +23.72% show the fundamental momentum is real. However, the multi-timeframe tape is NOT the clean 4-for-4 alignment we want. 1h and 4h forecasts are positive (fc_mid +12.84% and +2.62%), but the 1d timeframe is outright bearish (fc_short -6.55%, fc_mid -3.61%, fc_long -2.27%), and the bullish_prob is only 0.20 (well below the 0.55 threshold we like). The stock is pinned at the top of both the 1h and 4h ranges (pos_in_21bar_range_pct = 100), meaning we'd be chasing on the short intraday timeframes. The saving grace is the 1wk timeframe: -22.5% drawdown from the 21-bar high and only 27.87% position in range — that IS the pullback we want on a swing basis, and 1wk fc_mid is +11.85%. The conflict is real: near-term intraday says extended, daily model says pull back, weekly says accumulate. Combined with a bearish 1d model edge (that contradicts the screen's stated Model Edge ≥3% — worth flagging), the honest verdict is BUY_PULLBACK, not BUY_NOW. The fundamentals + UBS catalyst + weekly reset justify owning it, but chasing $10.52 at the 1h/4h range high with a -6.55% 1d forecast is poor risk/reward. Wait for a dip toward $10.00–$10.15 (mid-1wk range) to enter. No materially negative headlines — the news flow is clean and mildly positive (UBS Buy, Zacks note on outperformance). No dilution, no legal issues, no short-seller report. So the thesis isn't broken; the entry timing just needs discipline.